Equal Report: "For Companies of Medicines Equivalent Revenues to 6.8 Billion but Restrains Profitability"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.13 Articles
13 Articles
This is what emerges from the 11th Report of the Observatory on Accessible Drugs of Equalia, carried out with the contribution of Nomisma and TEHA Group and presented to the Auditorium of Ara Pacis.
(Adnkronos) "Accessible drug companies have borne the impact of rising costs, reorganizing processes and production without stopping to grow dimensionally and assume. But after years of adaptation comes a first sign of slowing down". It is recorded Equalia, the organ that represents the industry of generic equivalent drugs, biosimilar and value added medicines in Italy, in the 11th Report [...]
Calabria News
(Adnkronos) "Accessible drug companies have borne the impact of rising costs, reorganising processes and production without stopping to grow dimensionally and assume. But after years of adaptation comes a first sign of slowing down". It is recorded Equalia, the body representing the industry of generic equivalent drugs, biosimilar and value added medicines in Italy, in the 11th Report [...] L'articolo Report Equalia: "For companies of medicines …
Rec News | Lontani dal mainstream
notizie.it(Adnkronos) • The companies of accessible drugs have managed the impact of the increase of costs, reorganizing processes and production without stopping to grow dimensionally and to assume. But after years of adaptation comes a first signal of slowing down • • Equal, the organ that represents the industry of generic medicines equivalent, biosimilar and value added medicines in Italy, in the • XI Report [...] L'articolo Report Equal: •For the com…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
